Concepedia

Dillman Ro

DR

Statistics

Publications

8

Citations

209

H-Index

8

Active since

1983

Affiliations

Multimeric Biotherapeutics (United States)(Current)

Dillman Ro is an author at Multimeric Biotherapeutics (United States) specializing in medicine, oncology, and immunotherapy.

Publications per year

1983–1996

8

Publications

8

Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.

Dillman Ro, J Beauregard, Shawler Dl et al. · PubMed · 1986 · 55 citations

Medicine, Hematology, Oncology +14

Problems associated with radioimmunodetection and possibilities for future solutions.

Halpern Se, Dillman Ro · PubMed · 1987 · 45 citations

Medicine, Immunology, Pharmacology +17

Radioimmunodetection of cancer with the use of indium-111-labeled monoclonal antibodies.

Dillman Ro, J Beauregard, Ryan Kp et al. · PubMed · 1987 · 24 citations

Medicine, Nuclear Medicine, Oncology +17

Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial.

Oldham Rk, Dillman Ro, Yannelli et al. · PubMed · 1991 · 21 citations

Life Sciences, Immunology, Oncology +14

Transduction of human renal carcinoma cells with human gamma-interferon gene via retroviral vector.

Nayak Sk, Tammy J. McCallister, LJ Han et al. · PubMed · 1996 · 19 citations

Medicine, Cell Biology, Oncology +15

1–5 of 8